Extrahepatic manifestation of hepatitis may present a few weeks before clinical jaundice in acute hepatitis infection (
1). Hepatitis-associated aplastic anemia has been traditionally accompanied with non-A, non-B, and non-C viruses (
7). In a study on patients with aplastic anemia, 25% had a history of hepatitis which none of them were related to type A, B, C, D, E or G hepatitis (
8). The current case series is among few studies reported pancytopenia related to HAV infection. Previously, Das et al. reported a 10-year-old girl infected with HAV that developed pancytopenia (
3). In addition to HAV, hepatitis due to other viruses, including hepatitis G (HGV) and HCV has also been described along with pancytopenia (
9,
10). Despite that this is unusual, it is advisable to consider bone marrow failure in the patients infected with hepatitis and present with a decreased count of all blood cell lineages.
Pathogenesis of bone marrow failure following hepatitis infection remained a conundrum. Although the association of hemophagocytic syndrome (HPS) with HAV infection is a rare occasion (
11), Lymphohistiocytosis and HPS may share a notable role in hematopoietic suppression in the context of HAV infection (
1,
3). Nevertheless, HPS is generally seen in relation to infection of Epstein Barr virus, cytomegalovirus, Parvovirus B19, and herpes viruses type 6 and 8 (
12). The autoimmune nature of aplastic anemia related to hepatitis viruses has been proposed as a result of supporting findings such as deregulated T lymphocytic response and reversibility of the condition in response to immunosuppressive drugs are the two of strong documents (
13). An elevated ratio of CD8+ cytotoxic cells has been shown in liver sections obtained from patients with hepatitis-associated aplastic anemia (
14). Migration of a high number of such activated cells to bone marrow and induction of high levels of interferon- γ (IFN-γ) and Tumor Necrosis Factor-α (TNF-α) within bone marrow stroma can attenuate normal hematopoiesis (
15). Despite the facts that autoimmune hemolysis has been noted as a potential contributor to anemia in hepatitis (
5), none of our patients showed positive Coombs results. In addition, there has been a suggestion denoting a role for genetic determinants in the progression of hepatitis-associated pancytopenia. In spite of that no role has been considered for individuals’ features such as age and sex, or severity of the disease to contribute to the bone marrow failure in this condition (
8), younger male patients are more likely to develop hepatitis related pancytopenia (
13). Therapeutic regimens, especially those based on IFN-α and recently protease inhibitors have been described in relation to crippled hematopoiesis in hepatitis (
16).